GB201106803D0 - Sonodynamic therapy - Google Patents
Sonodynamic therapyInfo
- Publication number
- GB201106803D0 GB201106803D0 GBGB1106803.8A GB201106803A GB201106803D0 GB 201106803 D0 GB201106803 D0 GB 201106803D0 GB 201106803 A GB201106803 A GB 201106803A GB 201106803 D0 GB201106803 D0 GB 201106803D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- sonodynamic therapy
- sonodynamic
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
- A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1106803.8A GB201106803D0 (en) | 2011-04-21 | 2011-04-21 | Sonodynamic therapy |
PCT/GB2012/050894 WO2012143739A1 (en) | 2011-04-21 | 2012-04-23 | Sonodynamic therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1106803.8A GB201106803D0 (en) | 2011-04-21 | 2011-04-21 | Sonodynamic therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201106803D0 true GB201106803D0 (en) | 2011-06-01 |
Family
ID=44147386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1106803.8A Ceased GB201106803D0 (en) | 2011-04-21 | 2011-04-21 | Sonodynamic therapy |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201106803D0 (en) |
WO (1) | WO2012143739A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130123781A1 (en) | 2011-08-24 | 2013-05-16 | California Institute Of Technology | Targeting microbubbles |
WO2014142927A1 (en) * | 2013-03-14 | 2014-09-18 | Empire Technology Development Llc | Identification of surgical smoke |
US9255907B2 (en) | 2013-03-14 | 2016-02-09 | Empire Technology Development Llc | Identification of surgical smoke |
KR20150010908A (en) * | 2013-07-21 | 2015-01-29 | 더 스테이트 유니버시티 오브 뉴욕 버팔로 | Contrast agent for combined photoacoustic and ultrasound imaging |
US10646432B2 (en) | 2015-06-18 | 2020-05-12 | California Institute Of Technology | Synthesis and application of microbubble-forming compounds |
CN105233308B (en) * | 2015-11-02 | 2018-10-30 | 中国科学院深圳先进技术研究院 | A kind of acoustic contrast agent and the preparation method and application thereof for HIFU |
GB201520649D0 (en) | 2015-11-23 | 2016-01-06 | Univ Ulster | Sonodynamic therapy |
GB201708663D0 (en) * | 2017-05-31 | 2017-07-12 | Univ Ulster | Therapy |
WO2019050963A1 (en) * | 2017-09-05 | 2019-03-14 | University Of Pittsburgh -Of The Commonwealth System Of Higher Education | Sonodynamic therapy using microbubbles and pulsed wave ultrasound methods and systems |
CN108392641B (en) * | 2018-04-03 | 2020-12-01 | 深圳大学 | Nano emulsion and preparation method and application thereof |
CN108853520B (en) * | 2018-08-24 | 2021-04-13 | 重庆医科大学 | Sound-sensitive lipid nanoparticle, application and preparation method thereof |
CN109223800A (en) * | 2018-10-26 | 2019-01-18 | 辽宁大学 | Bis- para-totuidine base of 3,7--phenthazine -5- iodide and supersonic synergic are inhibiting the application in tumor cell proliferation |
GB201819853D0 (en) | 2018-12-05 | 2019-01-23 | Innovation Ulster Ltd | Therapy |
GB201908352D0 (en) | 2019-06-11 | 2019-07-24 | Innovation Ulster Ltd | Sonodynamic therapy |
CN110585447B (en) * | 2019-10-21 | 2021-11-16 | 广东医科大学 | Preparation method and application of aggregated luminescent nano-particle material capable of being used as sound sensitizer |
US10953023B1 (en) | 2020-01-28 | 2021-03-23 | Applaud Medical, Inc. | Phospholipid compounds and formulations |
CN111701030B (en) * | 2020-07-22 | 2022-12-27 | 西南大学 | Preparation method of active targeting zirconium dioxide nanoparticles with defect of acoustic power effect |
US20220313820A1 (en) * | 2020-08-27 | 2022-10-06 | Sahmyook University Industry-Academic Cooperation Foundation | Ultrasound-assisted drug delivery carrier using ultrasound contrast agent containing ligand conjugated with drug through ester bond |
US11813330B2 (en) | 2021-03-04 | 2023-11-14 | Theralase Technologies, Inc. | Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents |
CN116236570A (en) * | 2021-12-08 | 2023-06-09 | 深圳先进技术研究院 | Development and application of living organism self-oxygen-generating sound sensitizer |
CN116239153A (en) * | 2022-12-15 | 2023-06-09 | 浙江大学杭州国际科创中心 | FeMoO 4 Acid response sound power material and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
WO1999013943A1 (en) * | 1996-03-05 | 1999-03-25 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
US6416740B1 (en) * | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
EP2480127A4 (en) * | 2009-09-22 | 2015-06-24 | Targeson Inc | Optical imaging contrast agents and uses therof |
-
2011
- 2011-04-21 GB GBGB1106803.8A patent/GB201106803D0/en not_active Ceased
-
2012
- 2012-04-23 WO PCT/GB2012/050894 patent/WO2012143739A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012143739A1 (en) | 2012-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201106803D0 (en) | Sonodynamic therapy | |
ZA201305897B (en) | Combination therapy | |
ZA201400120B (en) | Combination therapy | |
PL2489413T3 (en) | Therapy device | |
HK1197178A1 (en) | Combination als therapy als | |
ZA201502595B (en) | Therapeutic methods | |
PL2723330T3 (en) | Vasoconstrictor-containing agent for combination therapy | |
EP2701744A4 (en) | Combination therapy | |
IL231564A0 (en) | Vaccine therapy | |
EP2687212A4 (en) | Medicament | |
ZA201308117B (en) | Avian-based treatment | |
GB201114226D0 (en) | Combination therapy | |
GB201120096D0 (en) | Novel therapy | |
GB201111247D0 (en) | Treatment | |
GB201109119D0 (en) | Treatment | |
GB201102269D0 (en) | Treatment | |
GB201102270D0 (en) | Treatment | |
GB201102277D0 (en) | Treatment | |
GB201102265D0 (en) | Treatment | |
GB201102275D0 (en) | Treatment | |
GB201102274D0 (en) | Treatment | |
GB201102273D0 (en) | Treatment | |
GB201102272D0 (en) | Treatment | |
GB201102271D0 (en) | Treatment | |
GB201102276D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |